Because the frequency of circulating mouse myeloid cell subsets was different between NSG-Quad and MISTRG-6 mice and may affect tumor growth and the tumor microenvironment (Figures S1D–S1G), we assessed the frequency of mouse CD45+ cells and myeloid cell subsets infiltrating the human CRC tumor xenografts. This evidence concerns the gene PTPRC and neoplasm.